BackgroundCheck.run
Search For

Young J Jung, 52Acton, MA

Known as:
Jou Young Jung Young J Han Jou Han Young Jou Young Han Youngjou Han Youngjou Jung Jou Jung Young Young J Jou-Jung Young Jou Oujung J Young Jung Young Jung Young Jou
Related to:
Eugene Cho 47

Young Jung Phones & Addresses

Acton, MA   

Derry, NH   

Windham, NH   

26 Meetinghouse Rd, Acton, MA 01720   

Work

Position: Production Occupations

Education

School / High School: George Mason University

Ranks

Licence: New York - Delinquent Date: 2002
Get Report
Control this profile

Mentions for Young J Jung

Career records & work history

Lawyers & Attorneys

Young Jung Photo 1

Young Hoon Jung - Lawyer

Address:
Mirae Asset Securities
Licenses:
New York - Delinquent 2002
Education:
George Mason University
Young Jung Photo 2

Young Jung - Lawyer

ISLN:
1000541192
Admitted:
2002

Medicine Doctors

Young Jung Photo 3

Young Seup Jung

Specialties:
Anesthesiology
Internal Medicine
Education:
Kyungpook National University (1972)

Young Jung resumes & CV records

Resumes

Young Jung Photo 51

Scientist Ii At Vertex Pharmaceuticals

Location:
Greater Boston Area
Industry:
Pharmaceuticals
Young Jung Photo 52

Scientistii At Biogenidec

Location:
Greater Boston Area
Industry:
Biotechnology
Young Jung Photo 53

Young Jung

Location:
United States
Young Jung Photo 54

Research Associate At Northeastern University

Location:
Greater Boston Area
Industry:
Higher Education
Young Jung Photo 55

Young Jung

Location:
United States
Young Jung Photo 56

Young Jung

Location:
United States

Publications & IP owners

Us Patents

Deuterated Hepatitis C Protease Inhibitors

US Patent:
8247532, Aug 21, 2012
Filed:
Nov 24, 2010
Appl. No.:
12/953876
Inventors:
Robert B. Perni - Marlborough MA, US
Youssef Bennani - Boston MA, US
Gregor Zlokarnik - La Jolla CA, US
Gerald J. Tanoury - Hudson MA, US
Minzhang Chen - Acton MA, US
Young Chun Jung - Lexington MA, US
Raymond E. Forslund - Natick MA, US
Francois Maltais - Tewksbury MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 38/04
US Classification:
530330
Abstract:
This invention relates to processes and intermediates for the preparation of salts of deuterated, enantiomericallv enriched alpha-amino beta-hydroxy acids of Formula 1.

Processes And Intermediates For Producing Azaindoles

US Patent:
8513414, Aug 20, 2013
Filed:
Jul 3, 2012
Appl. No.:
13/541504
Inventors:
Gerald J. Tanoury - Marlborough MA, US
Young Chun Jung - Lexington MA, US
Derek Magdziak - Medford MA, US
Adam Looker - Winchester MA, US
Billie J. Kline - Kingston MA, US
Václav Jurcik - Cambridge, GB
Beatriz Dominguez Olmo - Bury St Edmunds, GB
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D 401/14
US Classification:
544328
Abstract:
The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of Janus kinases (JAK).

Deuterated Hepatitis C Protease Inhibitors

US Patent:
2007022, Sep 27, 2007
Filed:
Mar 14, 2007
Appl. No.:
11/717991
Inventors:
Robert Perni - Marlborough MA, US
Youssef Bennani - Boston MA, US
Gregor Zlokarnik - La Jolla CA, US
Gerald Tanoury - Hudson MA, US
Minzhang Chen - Acton MA, US
Young Jung - Lexington MA, US
Raymond Forslund - Natick MA, US
Francois Maltais - Tewksbury MA, US
International Classification:
A61K 31/497
C07D 403/02
C07D 413/02
C07D 417/02
US Classification:
514255050, 544405000
Abstract:
A deuterated α-ketoamido steric specific compound of the formula wherein D denotes a deuterium atom on a steric specific carbon atom.

Processes And Intermediates For Preparing Steric Compounds

US Patent:
2007024, Oct 18, 2007
Filed:
Mar 14, 2007
Appl. No.:
11/724002
Inventors:
Gerald Tanoury - Hudson MA, US
Minzhang Chen - Acton MA, US
Young Jung - Lexington MA, US
Raymond Forslund - Natick MA, US
International Classification:
C07J 9/00
C07D 303/36
US Classification:
549553000, 552001000, 552548000, 562585000
Abstract:
This invention relates to processes and intermediates for the preparation of an alpha-amino beta-hydroxy acid of Formula 1 wherein the variables R, R′and Rare defined herein and the compound of Formula 1 has an enantiomeric excess (ee) of 55% or greater.

Processes And Intermediates For Preparing Steric Compounds

US Patent:
2013013, May 23, 2013
Filed:
Jan 14, 2013
Appl. No.:
13/740707
Inventors:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA, US
Minzhang Chen - Shanghai, CN
Young Chun Jung - Lexington MA, US
Raymond E. Forslund - Natick MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
International Classification:
C07C 231/12
C07C 247/06
C07C 59/255
C07J 75/00
C07J 9/00
C07D 303/48
C07C 51/41
US Classification:
549548, 564193, 552 12, 562585, 552550
Abstract:
This invention relates to processes and intermediates for the preparation of an alpha-amino beta-hydroxy acid of Formula 1wherein the variables R, R′and Rare defined herein and the compound of Formula 1 has an enantiomeric excess (ee) of 55% or greater.

Solid Forms Of A Thiophosphoramidate Nucleotide Prodrug

US Patent:
2013026, Oct 10, 2013
Filed:
Mar 11, 2013
Appl. No.:
13/794380
Inventors:
Ales Medek - Winchester MA, US
Lori Ann Ferris - Medford MA, US
Praveen Mudunuri - Waltham MA, US
Young Chun Jung - Lexington MA, US
David Richard Willcox - Wellesley MA, US
Michael Waldo - Grafton MA, US
William Aloysius Nugent - Manomet MA, US
International Classification:
C07H 19/10
A61K 45/06
A61K 31/7072
US Classification:
424 857, 536 268, 514 51, 424 854
Abstract:
The present application relates to solid state forms, for example, crystalline forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, pharmaceutical compositions that can include one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate, and methods of treating or ameliorating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate. Also disclosed herein are methods of treating diseases and/or conditions with one or more solid forms of 2′-C-methyluridine-5′-(O-phenyl-N—(S)-1-(isopropoxycarbonyl)ethyl)thiophosphoramidate in combination with one or more other agents.

Processes And Intermediates For Producing Azaindoles

US Patent:
2013030, Nov 14, 2013
Filed:
Jul 12, 2013
Appl. No.:
13/940421
Inventors:
Young Chun Jung - Lexington MA, US
Derek Magdziak - Medford MA, US
Adam Looker - Winchester MA, US
Billie J. Kline - Kingston MA, US
Václav Jurcik - Cambridge, GB
Beatriz Dominguez Olmo - Bury St Edmunds, GB
International Classification:
C07D 471/04
US Classification:
544328
Abstract:
The present invention relates to processes and intermediates for the preparation of compounds useful as inhibitors of Janus kinases (JAK).

Process Of Producing Cycloalkylcarboxamido-Indole Compounds

US Patent:
2013032, Dec 5, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/642642
Inventors:
Daniel T. Belmont - Grafton MA, US
Cristian Harrison - Beverly MA, US
Robert Michael Hughes - San Diego CA, US
Young Chun Jung - Lexington MA, US
Elaine Chungmin Lee - Arlington MA, US
Benjamin Joseph Littler - Carlsbad CA, US
Peter Jamison Rose - Littleton MA, US
David Andrew Siesel - San Diego CA, US
Gerald J. Tanoury - Marlborough MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - CAMBRIDGE MA
International Classification:
C07D 405/12
US Classification:
548454
Abstract:
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis.

Possible Relatives

Cynthia L Jung  David B Jung  Dawoon Jung  Dean Jung  Dae U Jung  Dale W Jung  Deborah Jung  Young A Johnson  Young E Kerr  Young I Kim 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.